Agenda - Day One | BioProcess International: COVID-19 Therapeutic Development & Production

Showing 1 of 1 Streams

Networking Break, Receptions and Registration

12:15 - 12:35

Registration

Showing 1 of 1 Streams

BioProcess International: COVID-19 Therapeutic Development & Production

12:35 - 12:45

Conference Opening Remarks

12:45 - 13:15

Keynote Opening Address: mRNA as a Platform Technology for Rapid Development of Vaccines Against Viral Infections – COVID-19 and Beyond

13:20 - 13:40

How New Platform Technologies will Reinvent Vaccine Manufacturing

13:45 - 14:05

Development, trial and scale up of the Oxford-AstraZeneca vaccine against COVID-19

Prof. Catherine Green - Associate Professor, Head of Clinical Biomanufacturing Facility, University of Oxford

14:05 - 14:25

Networking Break

14:25 - 14:45

Assessment of IFN Beta Therapies as Potential Treatments for COVID-19

14:50 - 15:10

Glycobiology of SARS-CoV2 and its Implications for Vaccine & Therapeutics

15:15 - 15:35

Scientific Track Presentation- Unlock the Potential of the mRNA Vaccine Platform with Integrated Production Processes from E. coli to Highly Purified mRNA

Aleš Štrancar - Managing Director, BIA Separations

15:40 - 16:00

Scientific Track Presentation-Agile Analytical Platforms for Vaccine Quality Control

Ashleigh Wake - Business Development Director, Intertek Pharmaceutical Services

Showing 1 of 1 Streams

Networking Break, Receptions and Registration

16:00 - 16:20

Networking Break and Live Labs

Showing 1 of 1 Streams

Funding, Policy & Regulatory Considerations for the Global Pandemic Response

16:25 - 16:45

Licensing requirements and procedures of COVID-19 vaccines in the pandemic situation

16:50 - 17:20

Afternoon Keynote: An Impressive, but not Perfect, Global Response to the Pandemic

17:20 - 17:50

Panel Discussion - Regulatory Impact of the Global Pandemic

Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC

Day OneSunday, 27 April 2025